Capital Fund Management (CFM)
BHVN

Capital Fund Management (CFM)’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Capital Fund Management (CFM)’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-7,115
Closed -$242K – 1756
2020
Q1 		$242K Buy
+7,115
New +$325K ﹤0.01% 1322
2019
Q3 		– Sell
-11,800
Closed -$517K – 2019
2019
Q2 		$517K Buy
+11,800
New +$665K ﹤0.01% 1212

Other funds holding BHVN

Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Fund Management (CFM)'s BHVN Position: Q2 2020 in Review

Capital Fund Management (CFM) sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q2 2020, closing a stake of 7,115 shares — an estimated $242K sold.

Capital Fund Management (CFM) first reported a position in BHVN in Q2 2019 and held it in 2 quarters. The position peaked at $517K in Q2 2019. 226 funds tracked by Wall St. Rank hold BHVN as of Q2 2020.

  • Capital Fund Management (CFM) reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q2 2020 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 7,115 Biohaven Pharmaceutical Holding Company Ltd. shares in Q2 2020, an estimated $242K.
  • Capital Fund Management (CFM) first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2019 and held it in 2 quarters.
  • Capital Fund Management (CFM)'s Biohaven Pharmaceutical Holding Company Ltd. position peaked at $517K in Q2 2019.
  • 226 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q2 2020.

Based on Capital Fund Management (CFM)'s 13F filing for Q2 2020, filed 13 Aug 2020.